Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CALVERT, H")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 25

  • Page / 1
Export

Selection :

  • and

ACTINIC GRANULOMA AND "BERKSHIRE NECK"GOODFELLOW A; CALVERT H.1980; BRIT. J. DERMATOL., SUPPL.; GBR; DA. 1980; VOL. 103; NO 18; PP. 75-77; BIBL. 3 REF.Article

FOCAL EPITHELIAL HYPERPLASIA OF THE ORAL MUCOSA: A CASE REPORT FROM THE UNITED KINGDOMGOODFELOW A; CALVERT H.1979; BRIT. J. DERMATOL.; GBR; DA. 1979; VOL. 101; NO 3; PP. 341-344; BIBL. 11 REF.Article

ANGIOKERATOMA CORPORIS DIFFUSUM (ANDERSON-FABRY DISEASE)GOODFELLOW A; CALVERT H.1980; BRIT. J. DERMATOL., SUPPL.; GBR; DA. 1980; VOL. 103; NO 18; PP. 45-46; BIBL. 1 REF.Article

HYPERTRICHOSIS LANUGINOSA ACQUISITAGOODFELLOW A; CALVERT H; BOHN G et al.1980; BR. J. DERMATOL. (1951); ISSN 0007-0963; GBR; DA. 1980; VOL. 103; NO 4; PP. 431-433; BIBL. 21 REF.Article

Synthetic Lethality to Overcome Cancer Drug Resistance : Cancer Chemoresistance and DNA RepairPORCELLI, L; QUATRALE, A. E; MANTUANO, P et al.Current medicinal chemistry. 2012, Vol 19, Num 23, pp 3858-3873, issn 0929-8673, 16 p.Article

Population pharmacokinetic and dynamic analysis of the topoisomerase I inhibitor lurtotecan in phase II studiesSCHELLENS, J. H. M; HEINRICH, B; CALVERT, H et al.Investigational new drugs. 2002, Vol 20, Num 1, pp 83-93, issn 0167-6997, 11 p.Article

Gene therapy for lung cancer. DiscussionWOLL, P. J; HART, I. R; OLIVER, T et al.Annals of oncology. 1995, Vol 6, pp S73-S77, issn 0923-7534, SUP1Conference Paper

Phase I―II study of plitidepsin and dacarbazine as first-line therapy for advanced melanomaPLUMMER, R; LORIGAN, P; KAHATT, C et al.British journal of cancer. 2013, Vol 109, Num 6, pp 1451-1459, issn 0007-0920, 9 p.Article

Surgical treatment of hepatic hydatid cystMCFALL, B; YOUSAF, M; CALVERT, H et al.International journal of clinical practice (Esher). 2004, Vol 58, Num 5, pp 479-482, issn 1368-5031, 4 p.Article

Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancerMAXWELL-ARMSTRONG, C. A; DURRANT, L. G; HARDCASTLE, J. D et al.British journal of cancer. 2001, Vol 84, Num 11, pp 1443-1446, issn 0007-0920Article

Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma : a study of the EORTC early clinical studies group (ECSG)PAVLIDIS, N; AAMDAL, S; WANDERS, J et al.Cancer chemotherapy and pharmacology. 2000, Vol 46, Num 2, pp 167-171, issn 0344-5704Article

Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclinesMARTIN, M; SPIELMANN, M; ZELEK, L et al.Annals of oncology. 2003, Vol 14, Num 8, pp 1246-1252, issn 0923-7534, 7 p.Article

A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancerGORE, M; OZA, A; RUSTIN, G et al.European journal of cancer (1990). 2002, Vol 38, Num 1, pp 57-63, issn 0959-8049Article

Temozolomide and treatment of malignant gliomaFRIEDMAN, H. S; KERBY, T; CALVERT, H et al.Clinical cancer research. 2000, Vol 6, Num 7, pp 2585-2597, issn 1078-0432Article

Identifying home advantage in international tennis and golf tournamentsNEVILL, A. M; HOLDER, R. L; BARDSLEY, A et al.Journal of sports sciences (Print). 1997, Vol 15, Num 4, pp 437-443, issn 0264-0414Article

A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignanciesARKENAU, H.-T; PLUMMER, R; CALVERT, H et al.Annals of oncology. 2012, Vol 23, Num 5, pp 1307-1313, issn 0923-7534, 7 p.Article

A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumorsMAHADEVAN, D; PLUMMER, R; VON HOFF, D et al.Annals of oncology. 2011, Vol 22, Num 9, pp 2137-2143, issn 0923-7534, 7 p.Article

A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancerRUSTIN, G; REED, N; GORE, M et al.Annals of oncology. 2011, Vol 22, Num 11, pp 2411-2416, issn 0923-7534, 6 p.Article

Activity of the dolastatin analogue, LU103793, in malignant melanomaSMYTH, J; BONETERRE, M. E; SCHELLENS, J et al.Annals of oncology. 2001, Vol 12, Num 4, pp 509-511, issn 0923-7534Article

Somatic genetic changes in lung cancer and precancerous lesions. DiscussionSUNDARESAN, V; HEPPELL-PARTON, A; KAYE, S et al.Annals of oncology. 1995, Vol 6, pp S27-S32, issn 0923-7534, SUP1Conference Paper

Evaluation of gastric emptying time in the J pouch compared with a standard esophagojejunal anastomosis. CommentaryMCALEESE, P; CALVERT, H; FERGUSON, W. R et al.World journal of surgery. 1993, Vol 17, Num 5, pp 595-600, issn 0364-2313Article

The Azolla-Anabaena azollae relationship. XII: Nitrogenase activity and phycobiliproteins of the endophyte as a function of leaf age and cell typeKAPLAN, D; CALVERT, H. E; PETERS, G. A et al.Plant physiology (Bethesda). 1986, Vol 80, Num 4, pp 884-890, issn 0032-0889Article

Nitrate induced regulation of nodule formation in soybeanMALIK, N. S. A; CALVERT, H. E; BAUER, W. D et al.Plant physiology (Bethesda). 1987, Vol 84, Num 2, pp 266-271, issn 0032-0889Article

Lichens to Gunnera: with emphasis on AzollaPETERS, G. A; TOIA, R. E. JR; CALVERT, H. E et al.Developments in plant and soil sciences. 1986, Vol 21, pp 17-34, issn 0167-840XArticle

Bacteriochlorophyll and photosynthetic reaction centers in Rhizobium strain BTAi 1EVANS, W. R; FLEISCHMAN, D. E; CALVERT, H. E et al.Applied and environmental microbiology (Print). 1990, Vol 56, Num 11, pp 3445-3449, issn 0099-2240, 5 p.Article

  • Page / 1